The oncogenic role of ARNTL2 in human cancer was firstly illustrated in hepatocellular carcinoma, Yeh et al. demonstrated that overexpression of ARNTL2 promotes cancer cell proliferation [25]. This evidence concerns the gene BMAL2 and hepatocellular carcinoma.